Early detection and treatment of<unk>  is known to reduce rates of morbidity and the chance of long-term pulmonary complications. Evidence shows that there is an association between achieving higher IgG levels and reduced infection frequency. If<unk>  remains undetected and untreated, outcomes are generally poor, especially if chronic lung damage or bronchiectasis has occurred. Unfortunately, the diagnosis of<unk>  is often significantly delayed.
Hypogammaglobulinemia
Hypergammaglobulinemia
Dysgammaglobulinemia
Monocytopenia
Thymic hypoplasia
Monoclonal B-cell lymphocytosis
Lymphocytopenia
Splenomegaly